Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Metabolic Rescue of Obese Adipose-Derived Stem Cells by Lin28/Let7 Pathway

  1. Laura M. Pérez1,
  2. Aurora Bernal1,
  3. Nuria San Martín1,
  4. Margarita Lorenzo2,†,
  5. Sonia Fernández-Veledo3,4 and
  6. Beatriz G. Gálvez1⇑
  1. 1Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  2. 2Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.
  3. 3University Hospital of Tarragona Joan XXIII, Pere Virgili Institute and Rovira i Virgili University,Tarragona, Spain.
  4. 4El Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  1. Corresponding author: Beatriz G. Gálvez, bgonzalez{at}cnic.es.
  • † Deceased.

Diabetes 2013 Jul; 62(7): 2368-2379. https://doi.org/10.2337/db12-1220
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Isolation and differentiation of ASCs. A: Proliferating ASCs emerging from adipose tissue explants. Bar, 150 μm. B: Flow cytometry characterization of ASCs from control (C57BL/6) and obese (ob/ob) mice. Mean fluorescence intensity (MFI) plus standard deviations of five independent experiments are shown. C: Percentages of differentiation into adipose (Adipo) (Oil Red O staining), chondrogenic (Chondro) (Toluidine Blue staining), or osteogenic (Osteo) (Alizarin Red staining) tissues of five different cASCs and oASCs were quantified by histochemistry. *P < 0.04. D: Representative image of Oil Red O staining in cASCs and oASCs differentiated for 7 days into adipocytes. Bar, 30 μm. E: Cell number (left) and cell size (right) analyzed by flow cytometry in cASCs and oASCs at day 7 of differentiation (n = 5). F: Intracellular lipid accumulation in differentiating ASCs (n = 5). *P < 0.03. G: Triglyceride (TG) content in differentiating cASCs and oASCs (n = 5). *P < 0.04. H: Gene expression profile of cASCs and oASCs at day 7 of differentiation (n = 5). *P < 0.02.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Glucose and lipid metabolism during ASC differentiation. A: Insulin-stimulated glucose uptake by cASC and oASC cultures at different stages of differentiation. Cells were stimulated with 10 nmol/L insulin (Ins) for 30 min. Results are expressed as pmol/mg protein (prot) per 10 min (n = 6), *P < 0.01. B: GLUT4 expression in 7-day differentiated cASCs and oASCs. Cells were stimulated for 20 min with 10 nmol/L insulin and lysed or fractioned. Plasma and internal membrane proteins, together with whole lysates, were analyzed by Western blot with anti–GLUT4 antibody; anti-caveolin (Cav)1, anti-PI3K, or anti-tubulin antibodies were used as controls. Densitometric bar graph quantification of three independent membranes is shown. O.D., optical density. *P < 0.05. C: Glycerol release from 7-day differentiated cASCs and oASCs. Cells were treated with 10 nmol/L insulin for 1 h before stimulation with 1 μmol/L isoproterenol (Iso) for 15 min (n = 6). *P < 0.03. D: NEFA release in 7-day differentiated ASCs treated as in C (n = 5). *P < 0.05. E: Activation of IRS1: 7-day differentiated ASCs were stimulated with 10 nmol/L insulin for 10 min and lysed. Total protein was analyzed by Western blot with anti-phospho- and anti-total IRS1, together with antitubulin antibodies. Densitometric bar graph quantification of three independent membranes is shown. *P < 0.05.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    The altered cytokine profile of oASCs transfers insulin resistance to cASC-derived adipocytes. A–C: cASCs and oASCs were differentiated for up to 7 days and cultured overnight in serum-free medium. Adiponectin, MPC-1, and TNF-α content were measured in conditioned medium (pg/mL) (n = 4). *P < 0.01. D and E: Effect of adipocyte-conditioned medium on insulin-stimulated glucose uptake. cASC- or oASC-derived 7-day adipocytes were cultured in the presence of conditioned medium from cCM or oCM for 24 h (n = 8). Cells were then maintained for 2 h in serum-free, low-glucose medium before stimulating with insulin (100 nmol/L, 30 min). Data are expressed as the percentage of the induced glucose uptake (stimulated – basal) in nontreated cells at 7-day differentiation (n = 8). *P < 0.01. F: oASC- and cASC-derived 7-day adipocytes were pretreated (24 h) with cCM or oCM of day 7, stimulated with 100 nmol/L Ins for 5 min, and lysates analyzed by Western blot with antibodies against phosphorylated and total IRS1. Densitometric bar graph quantification of three independent membranes is shown. O.D., optical density. *P < 0.05. G: Differentiation into mature adipocytes by cASC in the presence or absence of 1 ng/mL TNF-α or 0.2 ng/mL MCP-1 cytokines and by oASC in the presence or absence of 10 ng/mL anti–TNF-α or anti–MCP-1 antibodies. Oil Red O quantification of five independent experiments is shown. H: Insulin-stimulated glucose uptake by cASC-derived 7-day adipocytes in the presence or absence of 1 ng/mL TNF-α or 0.2 ng/mL MCP-1 cytokines and by oASC-derived 7-day adipocytes in the presence or absence of 10 ng/mL anti–TNF-α or anti–MCP-1 antibodies. Cells were stimulated with 10 nmol/L insulin (Ins) for 30 min. Results are expressed as pmol glucose/mg protein (prot)/10 min (n = 5). *P < 0.03, +P < 0.05. I: Gene expression profile at day 7 of differentiation of adipocytes derived from cASCs in the presence or absence of 1 ng/mL TNF-α or 0.2 ng/mL MCP-1 cytokines or from oASCs in the presence or absence of 10 ng/mL anti–TNF-α or anti–MCP-1 antibodies (Abs) (n = 5). *P < 0.04. Ctrl, control; Densi, densitometric; d, days.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Isolation and delivery of ASC subcellular fractions. A: Scheme for the isolation of cASC subcellular fractions and their transfer into oASCs. B: NFs and CFs were analyzed by agarose gel electrophoresis and Western blot for GADPH (cytosol marker) and SP1 (nuclear marker). A representative of three experiments is shown. C: Representative images of oASCs after transfer of NF or CF, called mASC, are shown (n = 8). Bar, 50 μm. D: Light microscopy and Oil Red O staining in adipocyte cultures differentiated (7 days) from oASCs and mASCs (CF transferred). Representative images are shown (n = 8). Bar, 30 μm. E: Gene expression profile after delivering of mASC (n = 5). *P < 0.02. F: Cell number (left) and cell size (right) analyzed by flow cytometry in oASCs and mASCs (n = 5).

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Transfer of cASC cytosol to oASCs restores nonobese metabolic parameters. A: Insulin-stimulated glucose uptake by adipocytes differentiated (7 days) from cASCs, oASCs, and mASCs. Adipocyte cultures were maintained overnight in serum-free, low-glucose medium and then stimulated with 10 nmol/L insulin (30 min; n = 6). *P < 0.01 between mASCs and oASCs. B and C: GLUT4 expression and IRS phosphorylation are restored in 7-day differentiated mASCs. cASCs, oASCs, and mASCs were stimulated with 10 nmol/L insulin for 10 min, and membrane fractions or cell lysates were probed by Western blot with anti–GLUT4 or anti-IRS1 antibodies. Densitometric quantification of three independent membranes is shown. *P < 0.03. D: Adiponectin, MCP-1, and TNF-α production by oASCs and mASCs. Cells were cultured overnight in serum-free medium, and adiponectin, MCP-1, and TNF-α were detected by immunoassay. Results are expressed as the percentage of detection comparing undifferentiated ASC at day 0 to differentiated ASC at day 7 (n = 6). *P < 0.02 between mASCs and oASCs. Densi, densitometric; Ins, insulin; prot, protein.

  • FIG. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Analysis of the CF content and its action mechanism. A and B: CFs, inactivated by proteinase-k (CFp) or by RNase cocktail (CFr), were delivered into oASC. Glucose uptake and the cell size-to-cell number ratio were measured in mASCs (n = 5). *P < 0.05. C: Analysis of Lin28 protein expression by Western blot in oASC-derived or cASC-derived CFs or in whole ASC lysates to note the restoration of Lin28 levels after cASC-derived CF (cCF) delivery into oASC (mASC). One representative image of three independent experiments is shown. D: Let7 microRNA expression was analyzed by RT-PCR (n = 5). *P < 0.04. E: Insulin-stimulated glucose uptake by adipocytes differentiated (7 days) from modified oASCs or oASC delivered with Lin28 protein. Adipocyte cultures were maintained overnight in serum-free, low-glucose medium and then stimulated with 10 nmol/L insulin (30 min; n = 5). *P < 0.03 between oASCs and mASCs or oASCs+Lin28. F: Representative images of Oil Red O–stained oASCs and oASC delivered with Lin28 protein after 7 days of differentiation into mature adipocytes (n = 5). Bar, 30 μm. G: Adiponectin, MCP-1, and TNF-α production by oASC-derived adipocytes (7 days) transferred or not with Lin28 and detected by immunoassay. Results are expressed as the percentage of detection comparing undifferentiated oASCs at day 0 to differentiated oASCs at day 7 (n = 5). *P < 0.02. H: Let7 microRNA and Lin28 expression were analyzed by RT-PCR in cASC-derived adipocytes (7 days) in the presence or absence of 1 ng/mL TNF-α or 0.2 ng/mL MCP-1 cytokines and in oASC-derived adipocytes in the presence or absence of 10 ng/mL anti–TNF-α or anti–MCP-1 antibodies (Abs) (n = 5). *P < 0.05 and **P < 0.02. d, days; Fibrob, fibroblast.

  • FIG. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    hASCs show similar obesity-related differentiation and metabolic alterations, which are rescued by transfer of cytosol from chASCs. A: Representative image of Oil Red O staining in chASC and ohASC differentiated for 14 days into adipocytes (n = 5 + 1). Bar, 30 μm. Cell number (left) and cell size (right) analyzed by flow cytometry in chASCs and ohASCs at day 14 of differentiation (n = 6). *P < 0.04. B: Insulin-stimulated glucose uptake by cASCs, oASCs, and cytosol-modified hASCs at 14-day differentiation. Cultures were stimulated with 10 nmol/L insulin (Ins) for 30 min, and results are expressed as pmol/mg of prot (prot)/10 min (n = 6). *P < 0.03. C: Glycerol release by cASCs, oASCs, and modified hASCs after 14-day differentiation. Cells were stimulated with 10 nmol/L Ins for 1 h before stimulation with 1 μmol/L isoproterenol (Iso) for 15 min. Results are expressed as nmol/mg of protein/3 h (n = 6). *P < 0.04. D: Adiponectin, MCP-1, and TNF-α production by hASCs. cASCs, oASCs, and modified hASCs were cultured overnight in serum-free medium, and adiponectin, MCP-1, and TNF-α were detected by immunoassay. Results are expressed as the percentage of detection comparing undifferentiated hASC at day 0 to differentiated hASC at day 14 (n = 6). *P < 0.03. E: Representative images of Oil Red O stained mhASC, ohASCs, and ohASC delivered with Lin28 protein after 14-day differentiation into mature adipocytes (n = 6). Bar, 30 μm. F: Analysis of Lin28 protein expression in ohASC-derived or cASC-derived CFs or in whole ASC lysates by Western blot. One of five independent experiments is shown. G: Let7 microRNA expression was analyzed by RT-PCR (n = 6). *P < 0.05. H: Insulin-stimulated glucose uptake by adipocytes differentiated (14 days) from obese modified hASCs, ohASC delivered with Lin28 protein or treated with anti-Let 7 inhibitor. Adipocyte cultures were maintained overnight in serum-free, low-glucose medium and then stimulated with 10 nmol/L insulin (30 min; n = 6). *P < 0.02.

PreviousNext
Back to top
Diabetes: 62 (7)

In this Issue

July 2013, 62(7)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic Rescue of Obese Adipose-Derived Stem Cells by Lin28/Let7 Pathway
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Metabolic Rescue of Obese Adipose-Derived Stem Cells by Lin28/Let7 Pathway
Laura M. Pérez, Aurora Bernal, Nuria San Martín, Margarita Lorenzo, Sonia Fernández-Veledo, Beatriz G. Gálvez
Diabetes Jul 2013, 62 (7) 2368-2379; DOI: 10.2337/db12-1220

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Metabolic Rescue of Obese Adipose-Derived Stem Cells by Lin28/Let7 Pathway
Laura M. Pérez, Aurora Bernal, Nuria San Martín, Margarita Lorenzo, Sonia Fernández-Veledo, Beatriz G. Gálvez
Diabetes Jul 2013, 62 (7) 2368-2379; DOI: 10.2337/db12-1220
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size
  • Lifestyle Intervention in Pregnant Women With Obesity Impacts Cord Blood DNA Methylation Which Associates With Body Composition in the Offspring
  • Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis
Show more Original Research

Obesity Studies

  • Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals
  • Muscular G9a Regulates Muscle-Liver-Fat Axis by Musclin Under Overnutrition in Female Mice
  • Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis
Show more Obesity Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.